1. Home
  2. HYPR vs ANIX Comparison

HYPR vs ANIX Comparison

Compare HYPR & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyperfine Inc.

HYPR

Hyperfine Inc.

HOLD

Current Price

$1.42

Market Cap

158.8M

Sector

Health Care

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.72

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYPR
ANIX
Founded
2014
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
158.8M
88.8M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
HYPR
ANIX
Price
$1.42
$2.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$1.59
$8.67
AVG Volume (30 Days)
749.5K
158.6K
Earning Date
05-12-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
23.21
12.82
EPS
N/A
N/A
Revenue
$13,563,000.00
$210,000.00
Revenue This Year
$50.75
N/A
Revenue Next Year
$29.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.22
N/A
52 Week Low
$0.68
$2.32
52 Week High
$2.22
$5.46

Technical Indicators

Market Signals
Indicator
HYPR
ANIX
Relative Strength Index (RSI) 46.38 51.99
Support Level $1.39 $2.38
Resistance Level $1.72 $3.12
Average True Range (ATR) 0.10 0.19
MACD 0.00 0.04
Stochastic Oscillator 17.19 61.54

Price Performance

Historical Comparison
HYPR
ANIX

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: